Herpes Simplex Completed Phase 3 Trials for Valaciclovir (DB00577)

Back to Herpes Simplex

Also known as: Herpesviral infection, unspecified / Herpes simplex (disorder) / HSV infection / Herpesviral [herpes simplex] infections / Herpes simplex NOS

IndicationStatusPhase
DBCOND0027882 (Herpes Simplex)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001649
Valaciclovir to Prevent Transmission of Herpes Simplex VirusTreatment
NCT00465205
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsPrevention
NCT01176409
Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?Treatment
NCT00378976
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.Prevention
NCT01602562
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation PatientsPrevention